Expanded Phenotype of the Cln6 Mouse Model

Area of Science:

• Neurogenetics
• Developmental Neuroscience
• Biomedical Research

Background:

• Neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative disorders.
• CLN6 disease, a form of NCL, presents with severe neurological symptoms and early mortality.
• Understanding CLN6 disease progression is crucial for developing effective treatments.

Purpose of the Study:

• To provide an in-depth characterization of a naturally occurring Cln6 mutant mouse model.
• To investigate the early pathological changes and phenotypic manifestations in Cln6 mice.
• To assess the utility of the Cln6 mouse model for translational research in CLN6 disease.

Main Methods:

• Phenotypic characterization of Cln6 mutant mice.
• Assessment of vision, motor function, and survival rates.
• Histopathological analysis including TUNEL staining for apoptosis and GFAP expression for astrogliosis.

Main Results:

• Cln6 mice exhibit early death, vision loss, and motor deficits.
• Retinal layer degeneration begins as early as postnatal day 14 (P14).
• Apoptosis and altered GFAP expression (astrogliosis) are observed in the brain and retina of Cln6 mice.

Conclusions:

• The Cln6 mouse model accurately recapitulates key pathological features of human CLN6 disease.
• Early onset of neurodegeneration and vision loss is evident in Cln6 mice.
• This model serves as a valuable tool for screening potential therapeutics for CLN6 disease.